Burns Market To Observe Strong Development By H2 2017

Overview

A burn is damage to body's tissues caused by heat, chemicals, electricity, sunlight or radiation. Symptoms include pain, increasing with each degree of burn, red and swollen skin, blisters and charred and blackened skin. Treatment includes antibiotics and pain relievers.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1773616-spinal-muscular-atrophy-sma-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Burns - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Burns (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 3, 4, 1, 14, 5 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Burns (Dermatology). 
- The pipeline guide reviews pipeline therapeutics for Burns (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Burns (Dermatology) therapeutics and enlists all their major and minor projects. 

Table of Contents 

Table of Contents 2 
List of Tables 4 
List of Figures 4 
Introduction 5 
Global Markets Direct Report Coverage 5 
Burns - Overview 6 
Burns - Therapeutics Development 7 
Pipeline Overview 7 
Pipeline by Companies 8 
Pipeline by Universities/Institutes 11 
Products under Development by Companies 12 
Products under Development by Universities/Institutes 14 
Burns - Therapeutics Assessment 15 
Assessment by Target 15 
Assessment by Mechanism of Action 17 
Assessment by Route of Administration 19 
Assessment by Molecule Type 21 
Burns - Companies Involved in Therapeutics Development 23 
AlgiPharma AS 23 
Alliance Pharma Plc 23 
Amarantus Bioscience Holdings Inc 24 
American Gene Technologies International Inc 24 
Anterogen Co Ltd 25 
CytoTools AG 25  

  .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1773616-spinal-muscular-atrophy-sma-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.